Antihyperglycemic, antihyperlipidemic, and renoprotective effects of Chlorella pyrenoidosa in diabetic rats exposed to cadmium

Toxicology Mechanisms and Methods

Volumn 22, Issue 8, 2012, Pages 617-624

  Senthilkumar, Thulasingam ^a   Sangeetha, Nagarajan ^a   Ashokkumar, Natarajan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Cadmium; Chlorella pyrenoidosa; Diabetic nephropathy; Hyperglycemia; Lipid profile

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHLORELLA PYRENOIDOSA EXTRACT; CHOLESTEROL; CREATININE; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CADMIUM POISONING; CHLORELLA; CHLORELLA PYRENOIDOSA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WISTAR ALBINO GLAXO RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CADMIUM CHLORIDE; CHLORELLA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENVIRONMENTAL POLLUTANTS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; KIDNEY; KIDNEY FUNCTION TESTS; LIPOPROTEINS; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR;

CHLORELLA PYRENOIDOSA; RATTUS;

EID: 84866540788     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.714007     Document Type: Article

References (49)

1. al-Shamaony L, al-Khazraji SM, Twaij HA. 1994. Hypoglycaemic efect of Artemisia herba alba. II. Efect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol 43:167-171.
2. Attman PO, Samuelsson O, Alaupovic P. 1993. Lipoprotein metabolism and renal failure. Am J Kidney Dis 21:573-592.
3. Attman PO, Samuelsson O. 2009. Dyslipidemia of kidney disease. Curr Opin Lipidol 20:293-299.
4. Belyaeva EA, Korotkov SM. 2003. Mechanism of primary Cd2+-induced rat liver mitochondria dysfunction: discrete modes of Cd2+ action on calcium and thiol-dependent domains. Toxicol Appl Pharmacol 192:56-68.
5. Bonnet F, Cooper ME. 2000. Potential infuence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetes Metab 26:254-264.
6. Bürgi W, Briner M, Franken N, Kessler AC. 1988. One-step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem 21:311-314.
7. Chávez E, Briones R, Michel B, Bravo C, Jay D. 1985. Evidence for the involvement of dithiol groups in mitochondrial calcium transport: studies with cadmium. Arch Biochem Biophys 242:493-497.
8. Chen HC, Guh JY, Chang JM, Hsieh MC, Shin SJ, Lai YH. 2005. Role of lipid control in diabetic nephropathy. Kidney Int Suppl 94:S60-S62.
9. Chen L, Lei L, Jin T, Nordberg M, Nordberg G F. 2006. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population. Diabetes Care 29:2682-2687.
10. Cherng JY, Shih MF. 2005. Preventing dyslipidemia by Chlorella pyrenoidosa in rats and hamsters after chronic high fat diet treatment. Life Sci 76:3001-3013.
11. Cherng JY, Shih MF. 2006. Improving glycogenesis in Streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci 78:1181-1186.
12. Doughman SD, Krupanidhi S, Sanjeevi CB. 2007. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev 3:198-203.
13. Edwards JR, Prozialeck WC. 2009. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 238:289-293.
14. Falholt K, Lund B, Falholt W. 1973. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 46:105-111.
15. Fawcett JK, Scott JE. 1960. A rapid and precise method for the determination of urea. J Clin Pathol 13:156-159.
16. Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purifcation of total lipides from animal tissues. J Biol Chem 226:497-509.
17. Forbes JM, Coughlan MT, Cooper ME. 2008. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446-1454.
18. Foster LB, Dunn RT. 1973. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem 19:338-340.
19. Friedewald W T, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
20. Guzmán S, Gato A, Lamela M, Freire-Garabal M, Calleja JM. 2003. Anti-infammatory and immunomodulatory activities of polysaccharide from Chlorella stigmatophora and Phaeodactylum tricornutum. Phytother Res 17:665-670.
21. Heidland A, Sebekova K, Schinzel R. 2001. Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis 38:S100-S106.
22. Hidaka S, Okamoto Y, Arita M. 2004. A hot water extract of Chlorella pyrenoidosa reduces body weight and serum lipids in ovariectomized rats. Phytother Res 18:164-168.
23. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. 2001. Progression of diabetic nephropathy. Kidney Int 59:702-709.
24. Hsu HY, Jeyashoke N, Yeh CH, Song YJ, Hua KF, Chao LK. 2010. Immunostimulatory bioactivity of algal polysaccharides from Chlorella pyrenoidosa activates macrophages via Toll-like receptor 4. J Agric Food Chem 58:927-936.
25. Jandeleit-Dahm K, Cao Z, Cox AJ, Kelly DJ, Gilbert RE, Cooper ME. 1999. Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl 71:S31-S36.
26. Jin T, Nordberg G, Sehlin J, Wallin H, Sandberg S. 1999. Te susceptibility to nephrotoxicity of streptozotocin-induced diabetic rats subchronically exposed to cadmium chloride in drinking water. Toxicology 142:69-75.
27. Jong-Yuh C, Mei-Fen S. 2005. Potential hypoglycemic efects of Chlorella in streptozotocin-induced diabetic mice. Life Sci 77:980-990.
28. Lee HS, Park HJ, Kim MK. 2008. Efect of Chlorella vulgaris on lipid metabolism in Wistar rats fed high fat diet. Nutr Res Pract 2:204-210.
29. Lynn EG, Siow YL, O K. 2000. Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells. Kidney Int 57:1472-1483.
30. Mayes PA, Botham KM. 2003. Lipid transport and storage. In: Murray RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's illustrated biochemistry. 26th ed. USA: McGraw-Hill Companies Inc; 205-218.
31. Merchant RE, Andre CA, Sica DA. 2002. Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food 5:141-152.
32. Ohkuwa T, Sato Y, Naoi M. 1995. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 56:1789-1798.
33. Pepato MT, Mori DM, Baviera AM, Harami JB, Vendramini RC, Brunetti IL. 2005. Fruit of the jambolan tree (Eugenia jambolana Lam.) and experimental diabetes. J Ethnopharmacol 96:43-48.
34. Peungvicha P, Tirawarapan SS, Temsiririrkkul R, Watanabe H, Kumar Prasain J, Kadota S. 1998. Hypoglycemic efect of the water extract of Piper sarmentosum in rats. J Ethnopharmacol 60:27-32.
35. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. 2006. Regulation of renal fatty acid and cholesterol metabolism, infammation, and fbrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55:2502-2509.
36. Rolandsson O, Haney MF, Hagg E, Biber B, Lernmark A. 2002. Streptozotocin induced diabetes in minipig: a case report of a possible model for type 1 diabetes? Autoimmunity 35:261-264.
37. Senthilkumar T, Ashokkumar N. 2012. Impact of Chlorella pyrenoidosa on the attenuation of hyperglycemia mediated oxidative stress and protection of kidney tissue in streptozotocin-cadmium induced diabetic nephropathic rats. Biomed Prev Nutr 2, 125-131.
38. Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. 2011. Neuroprotective efect of ginger on anti-oxidant enzymes in streptozotocin- induced diabetic rats. Food Chem Toxicol 49:893-897.
39. Sharmila Banu G, Kumar G, Murugesan AG. 2009. Antihyperlipidemic efect of Garlip, a polyherbal formulation in streptozotocin induced diabetic rats. Food Chem Toxicol 47:2361-2365.
40. Shibata S, Natori Y, Nishihara T, Tomisaka K, Matsumoto K, Sansawa H, Nguyen VC. 2003. Antioxidant and anti-cataract efects of Chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol 49:334-339.
41. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. 1983. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efciency. Clin Chem 29:1075-1080.
42. Spolaore P, Joannis-Cassan C, Duran E, Isambert A. 2006. Commercial applications of microalgae. J Biosci Bioeng 101:87-96.
43. Sun Z, Liu J, Zeng X, Huangfu J, Jiang Y, Wang M, Chen F. 2011. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Funct 2:251-258.
44. Tietz NW. 1987. Fundamentals of Clinical Chemistry. Philadelphia: WB Saunders Company. Trinder P. 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 24-27.
45. Utsunomiya K, Ohta H, Kurata H, Tajima N, Isogai Y. 1995. Te efect of macrophage colony-stimulating factor (M-CSF) on the progression of lipid-induced nephrotoxicity in diabetic nephropathy. J Diabetes Complicat 9:292-295.
46. Warnick GR, Nguyen T, Albers AA. 1985. Comparison of improved precipitation methods for quantifcation of high-density lipoprotein cholesterol. Clin Chem 31:217-222.
47. Yen TH, Lin JL, Lin-Tan DT, Hsu CW, Chen KH, Hsu HH. 2011. Blood cadmium level's association with 18-month mortality in diabetic patients with maintenance haemodialysis. Nephrol Dial Transplant 26:998-1005.
48. Yuan JP, Peng J, Yin K, Wang JH. 2011. Potential health-promoting efects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res 55:150-165.
49. Zilversmit DB, Davis AK. 1950. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 35:155-160.